Skip to main content
HR 1230 111th Congress House Health Advisory bodies Blood and blood diseases Environmental assessment, monitoring, research Environmental health Government information and archives Hazardous wastes and toxic substances Health care quality Health information and medical records Health programs administration and funding Medical research Medical tests and diagnostic methods Minority health Research administration and funding

To amend the Public Health Service Act to provide for research on acquired bone marrow failure diseases, minority-focused programs on such diseases, and the development of best practices for diagnosis of and care for individuals with such diseases.

Introduced: February 26, 2009 Introduced by: Matsui, Doris O. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 20 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 15, 2010
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 30, 2010
The title of the measure was amended. Agreed to without objection.
Sep 30, 2010
Motion to reconsider laid on the table Agreed to without objection.
Sep 30, 2010
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR 9/28/2010 H7193)
Sep 30, 2010
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR 9/28/2010 H7193)
Sep 30, 2010
Considered as unfinished business. (consideration: CR H7380)
Sep 28, 2010
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Burgess objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.
Sep 28, 2010
DEBATE - The House proceeded with forty minutes of debate on H.R. 1230.
Sep 28, 2010
Considered under suspension of the rules. (consideration: CR H7193-7194)
Sep 28, 2010
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 28, 2010
Placed on the Union Calendar, Calendar No. 377.
Sep 28, 2010
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 111-637.
Sep 23, 2010
Ordered to be Reported (Amended) by Voice Vote.
Sep 23, 2010
Committee Consideration and Mark-up Session Held.
Sep 16, 2010
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Sep 16, 2010
Subcommittee Consideration and Mark-up Session Held.
Sep 15, 2010
Subcommittee Hearings Held.
Mar 6, 2009
Referred to the Subcommittee on Health.
Feb 26, 2009
Referred to the House Committee on Energy and Commerce.
Feb 26, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010 - (Sec. 2) Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to conduct research on acquired bone marrow failure diseases, which may address factors including: (1) trends in the characteristics of individuals who are diagnosed with such diseases, including age, race and ethnicity, general geographic location, sex, and family history; (2) the genetic and environmental factors, including exposure to toxins, that may be associated with developing such diseases; (3) approaches to treating such diseases; and (4) outcomes for individuals treated for such diseases, including outcomes for recipients of stem cell therapeutic products.

Authorizes the Secretary to collaborate with the Radiation Injury Treatment Network of the C.W. Bill Young Cell Transplantation Program to: (1) augment data for studies; (2) access technical assistance that may be provided by the Network; or (3) perform joint research projects.

(Sec. 3) Authorizes the Secretary to establish and coordinate outreach and informational programs targeted to minority populations, including Hispanic, Asian-American, Native Hawaiian, and Pacific Islander populations, that are affected by acquired bone marrow failure diseases. Includes among program activities: (1) making information about treatment options and clinical trials for such diseases publicly available; and (2) providing referral services for treatment options and clinical trials.

(Sec. 4) Authorizes the Secretary, acting through the Director of the Agency for Healthcare Research and Quality, to award grants to researchers to study best practices with respect to diagnosing acquired bone marrow failure diseases and providing care to individuals with such diseases.

What's happening now November 15, 2010

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 3
 Cosponsors 12
All 12 Democratic 12